In The News Posted March 22, 2019 Share Posted March 22, 2019 MONTEVIDEO, Uruguay, March 22, 2019 /PRNewswire/ -- Biotoscana Investments S.A. (B3: GBIO33), a biopharmaceutical group that operates in Latin America, announced today its results for the 4Q18 and 2018. HIGHLIGHTS Net revenues for 2018 increased by 10% in constant currency, positively... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.